Brief: Dawnrays Pharmaceutical says change of CEO
April 18 (Reuters) - Dawnrays Pharmaceutical Holdings Ltd 2348.HK : * Pharma-...more announcement change of chief executive officer 2348.HK * Chen shaojun, the executive vice president of the company, has been appointed as the chief executive officer * Li kei ling, chairman, ceased to be chief executive officer of the company with effect from 18 April 2016 * Source text (http://bit.ly/1Te1NfH) ((For more news, please click here 2348.HK )) ((Bengaluru Newsroom; +91 80 6749 1130))
Recent news on Dawnrays Pharmaceutical (Holdings)
See all newsBrief: Dawnrays Pharmaceutical Says Suzhou Dawnrays Commits To Invest Up To RMB100 Mln In Partnership
Brief: Dawnrays Pharmaceutical (Holdings) Final Dividend Of Hk$0.048 Per Share
Brief: Dawnrays Pharmaceutical Reports HY Net Income Attributable Of RMB104.6 MLN
Brief: Dawnrays Pharmaceutical (Holdings) Posts FY Profit Attributable Of Rmb564.9 Million
Brief: Dawnrays Pharmaceutical (Holdings) Appoints Yu Liwei To Act As CEO